Innoforce Pharmaceuticals - Crunchbase Company Profile & Funding

Q: Who invested in Innoforce Pharmaceuticals?

Innoforce Pharmaceuticals has 9 investors including TriWise Capital And China Highrun Capital Limited.

Q: How much funding has Innoforce Pharmaceuticals raised to date?

Innoforce Pharmaceuticals has raised obfuscated.

Overview

Innoforce Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Innoforce Pharmaceuticals

CB Rank

83167

Innoforce is a biopharma manufacturing firm that facilitates the development and commercialization of innovative medicines.

Founded

obfuscation

Private

Series A

Hangzhou, Zhejiang, China

101-250

www.innoforcepharma.com/

Biopharma

Biotechnology

Health Care

Manufacturing

Pharmaceutical

Funding Rounds

Series A

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Yuling (Elaine) Li: CEO
Kenneth Carter: Global Head of Corporate Development & President of US Operations
Past Role: Human Genome Sciences, Various Positions

Details

Legal Name

Innoforce Pharmaceuticals Co., Ltd.

Also Known As

Innoforce

Operating Status

Active

Company Type

For Profit

Founders

Yuling (Elaine) Li

About the Company

Innoforce is a biopharma manufacturing firm that facilitates the development and commercialization of innovative medicines.

Phone Number

86-571-82816999

Contact Email

info@innoforcepharma.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Plasmid DNA

Manufacture of plasmid DNA as a starting material for advanced therapy medicinal products, supporting pre-clinical to commercial phases.

RNA IVT (In Vitro Transcription) Drug Substance

Production of mRNA drug substances using in vitro transcription technology for therapeutic applications.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Innoforce Pharmaceuticals	9	obfuscated obfuscation	South China Venture Capital, Yanchuang Capital	Series A
obfuscated obfuscation	Series A - Innoforce Pharmaceuticals	9	obfuscated obfuscation	South China Venture Capital, Yanchuang Capital	Series A
obfuscated obfuscation	Series A - Innoforce Pharmaceuticals	9	obfuscated obfuscation	South China Venture Capital, Yanchuang Capital	Series A
obfuscated obfuscation	Series A - Innoforce Pharmaceuticals	9	obfuscated obfuscation	South China Venture Capital, Yanchuang Capital	Series A
obfuscated obfuscation	Series A - Innoforce Pharmaceuticals	9	obfuscated obfuscation	South China Venture Capital, Yanchuang Capital	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Innoforce Pharmaceuticals	9	obfuscated obfuscation	South China Venture Capital, Yanchuang Capital	Series A
obfuscated obfuscation	Series A - Innoforce Pharmaceuticals	9	obfuscated obfuscation	South China Venture Capital, Yanchuang Capital	Series A
obfuscated obfuscation	Series A - Innoforce Pharmaceuticals	9	obfuscated obfuscation	South China Venture Capital, Yanchuang Capital	Series A
obfuscated obfuscation	Series A - Innoforce Pharmaceuticals	9	obfuscated obfuscation	South China Venture Capital, Yanchuang Capital	Series A
obfuscated obfuscation	Series A - Innoforce Pharmaceuticals	9	obfuscated obfuscation	South China Venture Capital, Yanchuang Capital	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
TriWise Capital	—	Series A - Innoforce Pharmaceuticals	—
TriWise Capital	—	Series A - Innoforce Pharmaceuticals	—
TriWise Capital	—	Series A - Innoforce Pharmaceuticals	—
TriWise Capital	—	Series A - Innoforce Pharmaceuticals	—
TriWise Capital	—	Series A - Innoforce Pharmaceuticals	—